Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Top Cited Papers
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 360 (9337), 895-900
- https://doi.org/10.1016/s0140-6736(02)11024-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: Response to iloprost inhalationJournal of the American College of Cardiology, 2001
- Predicting Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary HypertensionCirculation, 2001
- Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin AnalogueNew England Journal of Medicine, 2000
- Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled TrialAnnals of Internal Medicine, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Aerosolised prostacyclin in adult respiratory distress syndromeThe Lancet, 1993
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993